Quest Diagnostics (NYSE:DGX – Get Free Report) had its price objective lifted by equities researchers at Robert W. Baird from $190.00 to $191.00 in a note issued to investors on Thursday,Benzinga ...
In this episode of Lessons in Leadership, Steve Adubato and Mary Gamba talk with Cecilia McKenney, SVP & Chief Human Resources Officer, Quest Diagnostics, about the keys to recruiting, training, and ...
Quest Diagnostics teams up with Google Cloud to streamline data and personalize customer experiences using gen AI.
In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Hold rating on Quest Diagnostics (DGX – Research Report), ...
Under the partnership, the Secaucus-based company becomes the first national laboratory to implement these services across a range of areas.
Quest Diagnostics logged a -1.0% change during today's afternoon session, and is now trading at a price of $166.27 per share.
Public health labs have handled most testing thus far for the Texas and New Mexico outbreaks, but commercial labs are beginning to bring molecular measles assays online.
The board of Quest Diagnostics Incorporated ( NYSE:DGX ) has announced that it will be paying its dividend of $0.80 ...
Proponents herald the practice as a free-market approach to providing medical care, while critics say it could widen health ...
This was the stock's second consecutive day of losses.
2d
Zacks Investment Research on MSNTap Billion-Dollar AI Opportunity in Oncology: Stocks in the SpotlightArtificial Intelligence (AI) and Machine Learning (ML) play a pivotal role in precision oncology, analyzing vast datasets, ...
Shares of Quest Diagnostics (NYSE: NYSE:DGX) tumbled 4.75% today after the company provided long-term guidance that failed to meet investor expectations. Despite reaffirming its full-year 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results